Literature DB >> 29678959

Extracellular vesicles and their content in bioactive lipid mediators: more than a sack of microRNA.

Eric Boilard1.   

Abstract

Extracellular vesicles (EVs), such as exosomes and microvesicles, are small membrane-bound vesicles released by cells under various conditions. In a multitude of physiological and pathological conditions, EVs contribute to intercellular communication by facilitating exchange of material between cells. Rapidly growing interest is aimed at better understanding EV function and their use as biomarkers. The vast EV cargo includes cytokines, growth factors, organelles, nucleic acids (messenger and micro RNA), and transcription factors. A large proportion of research dedicated to EVs is focused on their microRNA cargo; however, much less is known about other EV constituents, in particular, eicosanoids. These potent bioactive lipid mediators, derived from arachidonic acid, are shuttled in EVs along with the enzymes in charge of their synthesis. In the extracellular milieu, EVs also interact with secreted phospholipases to generate eicosanoids, which then regulate the transfer of cargo into a cellular recipient. Eicosanoids are useful as biomarkers and contribute to a variety of biological functions, including modulation of distal immune responses. Here, we review the reported roles of eicosanoids conveyed by EVs and describe their potential as biomarkers.
Copyright © 2018 Boilard.

Entities:  

Keywords:  cancer; eicosanoids; exosomes; microvesicles; neutrophils; platelets

Mesh:

Substances:

Year:  2018        PMID: 29678959      PMCID: PMC6210911          DOI: 10.1194/jlr.R084640

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  113 in total

Review 1.  Morphogen gradient formation and vesicular trafficking.

Authors:  Eugeni V Entchev; Marcos A González-Gaitán
Journal:  Traffic       Date:  2002-02       Impact factor: 6.215

2.  Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor.

Authors:  C Weber; T A Springer
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 3.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

4.  Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.

Authors:  H F Heijnen; A E Schiel; R Fijnheer; H J Geuze; J J Sixma
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

5.  Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer.

Authors:  Jian-Guo Wang; Julia E Geddings; Maria M Aleman; Jessica C Cardenas; Pichika Chantrathammachart; Julie C Williams; Daniel Kirchhofer; Vladimir Y Bogdanov; Ronald R Bach; Janusz Rak; Frank C Church; Alisa S Wolberg; Rafal Pawlinski; Nigel S Key; Jen Jen Yeh; Nigel Mackman
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

6.  Induction of myeloid-derived suppressor cells by tumor exosomes.

Authors:  Xiaoyu Xiang; Anton Poliakov; Cunren Liu; Yuelong Liu; Zhong-bin Deng; Jianhua Wang; Ziqiang Cheng; Spandan V Shah; Gui-Jun Wang; Liming Zhang; William E Grizzle; Jim Mobley; Huang-Ge Zhang
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

7.  On the binding preference of human groups IIA and X phospholipases A2 for membranes with anionic phospholipids.

Authors:  Sofiane Bezzine; James G Bollinger; Alan G Singer; Sarah L Veatch; Sarah L Keller; Michael H Gelb
Journal:  J Biol Chem       Date:  2002-09-19       Impact factor: 5.157

8.  Caspase-mediated inhibition of human cytosolic phospholipase A2 during apoptosis.

Authors:  S Adam-Klages; R Schwandner; S Lüschen; S Ussat; D Kreder; M Krönke
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

9.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells.

Authors:  O Fourcade; M F Simon; C Viodé; N Rugani; F Leballe; A Ragab; B Fournié; L Sarda; H Chap
Journal:  Cell       Date:  1995-03-24       Impact factor: 41.582

10.  Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization.

Authors:  Karine Laulagnier; Claude Motta; Safouane Hamdi; Sébastien Roy; Florence Fauvelle; Jean-François Pageaux; Toshihide Kobayashi; Jean-Pierre Salles; Bertrand Perret; Christian Bonnerot; Michel Record
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

View more
  58 in total

1.  LTB4 and 5-oxo-ETE from extracellular vesicles stimulate neutrophils in granulomatosis with polyangiitis.

Authors:  Marcin Surmiak; Anna Gielicz; Darko Stojkov; Rafał Szatanek; Katarzyna Wawrzycka-Adamczyk; Shida Yousefi; Hans-Uwe Simon; Marek Sanak
Journal:  J Lipid Res       Date:  2019-11-18       Impact factor: 5.922

Review 2.  Co-opting oxylipin signals in microbial disease.

Authors:  Mengyao Niu; Nancy P Keller
Journal:  Cell Microbiol       Date:  2019-06       Impact factor: 3.715

Review 3.  Unpacking the Role of Extracellular Vesicles in Ischemic and Hemorrhagic Stroke: Pathophysiology and Therapeutic Implications.

Authors:  Yonatan Hirsch; Joseph R Geraghty; Cory R Reiter; Eitan A Katz; Conner F Little; Matthew K Tobin; Fernando D Testai
Journal:  Transl Stroke Res       Date:  2022-05-06       Impact factor: 6.829

4.  Profile of circulating extracellular vesicles microRNA correlates with the disease activity in granulomatosis with polyangiitis.

Authors:  Marcin Surmiak; Katarzyna Wawrzycka-Adamczyk; Joanna Kosałka-Węgiel; Stanisław Polański; Marek Sanak
Journal:  Clin Exp Immunol       Date:  2022-05-13       Impact factor: 4.330

Review 5.  Platelets and extracellular vesicles and their cross talk with cancer.

Authors:  Sophia Lazar; Lawrence E Goldfinger
Journal:  Blood       Date:  2021-06-10       Impact factor: 22.113

6.  Macrophage Exosomes Resolve Atherosclerosis by Regulating Hematopoiesis and Inflammation via MicroRNA Cargo.

Authors:  Laura Bouchareychas; Phat Duong; Sergio Covarrubias; Eric Alsop; Tuan Anh Phu; Allen Chung; Michael Gomes; David Wong; Bessie Meechoovet; Allyson Capili; Ryo Yamamoto; Hiromitsu Nakauchi; Michael T McManus; Susan Carpenter; Kendall Van Keuren-Jensen; Robert L Raffai
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

Review 7.  Extracellular vesicles in obesity and its associated inflammation.

Authors:  Vijay Kumar; Sonia Kiran; Santosh Kumar; Udai P Singh
Journal:  Int Rev Immunol       Date:  2021-08-23       Impact factor: 5.311

Review 8.  Platelet Extracellular Vesicles: Beyond the Blood.

Authors:  Florian Puhm; Eric Boilard; Kellie R Machlus
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-08       Impact factor: 8.311

Review 9.  Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis.

Authors:  Adriana Georgescu; Maya Simionescu
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 10.  Antiplatelet Effects of PCSK9 Inhibitors in Primary Hypercholesterolemia.

Authors:  Piotr Pęczek; Mateusz Leśniewski; Tomasz Mazurek; Lukasz Szarpak; Krzysztof J Filipiak; Aleksandra Gąsecka
Journal:  Life (Basel)       Date:  2021-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.